ArticleThe New England journal of medicine2018

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.